Product Liability Forecast: More Suits, Smaller Scale
This article was originally published in RPM Report
Executive Summary
More than 20 drugs are the subject of multidistrict product liability litigation, but none of the pending cases approach the scope of past lawsuits against Merck’s Vioxx and Lilly’s Zyprexa. That may be one silver lining for Big Pharma as the blockbuster era draws to a close.
You may also be interested in...
US FDA Takes Star Turn In Recent Drug Ingredient Liability Lawsuits
Agency’s direct involvement in pharma product liability litigation is one of the most striking developments in the field over the past year; 16 cases in multidistrict litigation listed in chart showing status of settlements and upcoming bellwether trials.
US FDA Takes Star Turn In Recent Product Liability Lawsuits
Agency’s direct involvement in pharma product liability litigation is one of the most striking developments in the field over the past year. Chart of 16 cases in multidistrict litigation shows status of settlements and upcoming bellwether trials.
After 5-Year Winning Streak, Xarelto Makers Settle Personal Injury Suits
Bayer and Johnson & Johnson agree to resolve approximately 25,000 claims in federal and state courts for $775m, almost 13% of Xarelto's 2018 sales.